Empiric Azithromycin Alters the Upper Respiratory Microbiome and Resistome Without Anti-Inflammatory Benefit in COVID-19

CTSA https://pubmed.ncbi.nlm.nih.gov/41840216/ 2026-03-16T00:00:00Z Nature Microbiology